Propofol Use in Patients with Pulmonary Hypertension

Introduction to Propofol Risks

Propofol should be used with extreme caution in patients with pulmonary hypertension due to its potential to cause significant hemodynamic instability, particularly decreased cardiac output, systemic vascular resistance, and arterial pressure, as recommended by the American College of Critical Care Medicine 1, 2

Propofol causes dose-dependent respiratory depression and hypotension due to systemic vasodilation, which can be particularly problematic in patients with pulmonary hypertension, according to the American College of Critical Care Medicine 1, 3
The cardiovascular effects include decreases in cardiac output, systemic vascular resistance, and arterial pressure, which can worsen right ventricular function in patients with pulmonary hypertension, as stated by the American Gastroenterological Association 2, 4

Cardiopulmonary instability with propofol administration is more likely to occur in patients with baseline respiratory insufficiency and/or cardiovascular instability, which are common in pulmonary hypertension, as noted by the American College of Critical Care Medicine 1
Negative cardiac inotropy and respiratory depression can be seen with propofol use, although these effects typically respond rapidly to dose reduction or interruption of drug infusion, as reported by the American Gastroenterological Association 4
Continuous monitoring of heart rate, blood pressure, and pulse oximetry is essential during propofol administration in these high-risk patients, as recommended by the American College of Critical Care Medicine 2

Administer intravenous propofol in small, incremental doses or by slow infusion, carefully titrating to the desired endpoints, as suggested by the American College of Critical Care Medicine 2
Allow sufficient time between doses to assess the peak effect of each dose before subsequent administration, as recommended by the American College of Critical Care Medicine 2
Be prepared for rapid intervention if hemodynamic compromise occurs, including immediate discontinuation of propofol, administration of intravenous fluids, and use of vasopressors if needed, as stated by the American College of Critical Care Medicine 1, 2, 3